Sung-Bae Kim

43PUBLICATIONS
377CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAllergyHealth and ecological risk assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Jul 13, 2026
A Randomized, Nivolumab-controlled, Phase 2 and Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus.

|Apr 01, 2026
A Real-World Efficacy and Safety of KEYNOTE-522 Regimen in Patients With Early Triple-Negative Breast Cancer.

Shinyoung Lee, Hyehyun Jeong, Yeokyeong Shin

|Mar 31, 2026
Prognostic Significance of Pretreatment ¹⁸F-FDG PET/CT Parameters in Patients With ER+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors Plus Endocrine Therapy.

Minseung Suh, Jeongryul Ryu, Hojin Song

|Mar 09, 2026
VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer.

Sara A Hurvitz, Rachel M Layman, Giuseppe Curigliano

|Sep 29, 2025
Prognostic Value of Neutrophil-Lymphocyte Ratio Change After Short-Term Chemotherapy in De Novo Stage IV Breast Cancer Patients.

Haena Shin, Sei-Hyun Ahn, Sae Byul Lee

|Jun 13, 2025
LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC.

Jean-Pascal Machiels, Jérôme Fayette, Robert Haddad

Pageof 8

Frequent Collaborators

7 joint publications

Jae Ho Jung

6 joint publications

Gyungyub Gong

6 joint publications

Kyung Hae Jung

6 joint publications

Seock-Ah Im